EMPLOYMENT AGREEMENT effective as of December 1, 2017 (hereinafter referred to as the “Effective Date”) betweenEmployment Agreement • December 21st, 2017 • CRISPR Therapeutics AG • Biological products, (no disgnostic substances)
WHEREAS, the Executive transitioned from his position as Chief Executive Officer of the Company to President of the Company effective as of the Effective Date (the “Position Change”);
ADVISORY AGREEMENTAdvisory Agreement • December 21st, 2017 • CRISPR Therapeutics AG • Biological products, (no disgnostic substances) • Massachusetts
This ADVISORY AGREEMENT (the “Agreement”) is made as of the 20th day of December, 2017 (the “Effective Date”), by and between CRISPR Therapeutics AG (“CRISPR” or, along with its affiliates the “Company”) and N. Anthony Coles, MD (“Coles”).
